Search Results

There are 8609 results for: content related to: Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease

  1. Identification of a potential tumor differentiation factor receptor candidate in prostate cancer cells

    FEBS Journal

    Volume 279, Issue 14, July 2012, Pages: 2579–2594, Izabela Sokolowska, Alisa G. Woods, Mary Ann Gawinowicz, Urmi Roy and Costel C. Darie

    Article first published online : 14 JUN 2012, DOI: 10.1111/j.1742-4658.2012.08641.x

  2. You have full text access to this OnlineOpen article
    No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus

    Hepatology

    Volume 53, Issue 3, March 2011, Pages: 763–773, Andrea Snow-Lampart, Brandi Chappell, Maria Curtis, Yuao Zhu, Florence Myrick, James Schawalder, Kathryn Kitrinos, Evguenia S. Svarovskaia, Michael D. Miller, Jeff Sorbel, Jenny Heathcote, Patrick Marcellin and Katyna Borroto-Esoda

    Article first published online : 22 DEC 2010, DOI: 10.1002/hep.24078

  3. The Neurochemical Basis for the Behavioral Effects of Triadimefon

    Annals of the New York Academy of Sciences

    Volume 914, Issue 1, September 2000, Pages: 336–353, DONNA HILL, MARGARETMARY IKAIDDI, ELIZABETH MAZZIO and KARAM F.A. SOLIMAN

    Article first published online : 25 JAN 2006, DOI: 10.1111/j.1749-6632.2000.tb05209.x

  4. You have full text access to this OnlineOpen article
    Cost–Utility Analysis of Tenofovir Disoproxil Fumarate in the Treatment of Chronic Hepatitis B

    Value in Health

    Volume 13, Issue 8, December 2010, Pages: 922–933, Helen Dakin, Anthony Bentley and Geoff Dusheiko

    Article first published online : 3 SEP 2010, DOI: 10.1111/j.1524-4733.2010.00782.x

  5. Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir

    Journal of Viral Hepatitis

    Volume 19, Issue 3, March 2012, Pages: 213–219, C. Q. Pan, K.-Q. Hu, A. S. Yu, W. Chen, C. Bunchorntavakul and K. R. Reddy

    Article first published online : 17 OCT 2011, DOI: 10.1111/j.1365-2893.2011.01533.x

  6. You have free access to this content
    Structural investigation of tumor differentiation factor

    Biotechnology and Applied Biochemistry

    Volume 59, Issue 6, November-December 2012, Pages: 445–450, Urmi Roy, Izabela Sokolowska, Alisa G. Woods and Costel C. Darie

    Article first published online : 20 NOV 2012, DOI: 10.1002/bab.1046

  7. High Genetic Barrier Nucleos(t)ide Analogue(s) for Prophylaxis From Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review

    American Journal of Transplantation

    Volume 13, Issue 2, February 2013, Pages: 353–362, E. Cholongitas and G.V. Papatheodoridis

    Article first published online : 8 NOV 2012, DOI: 10.1111/j.1600-6143.2012.04315.x

  8. You have full text access to this OnlineOpen article
    First-line treatment of chronic hepatitis B with entecavir or tenofovir in ‘real-life’ settings: from clinical trials to clinical practice

    Journal of Viral Hepatitis

    Volume 19, Issue 6, June 2012, Pages: 377–386, S. Pol and P. Lampertico

    Article first published online : 28 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01602.x

  9. You have full text access to this OnlineOpen article
    Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations

    HIV Medicine

    Volume 10, Issue 4, April 2009, Pages: 229–235, J Audsley, N Arrifin, LKW Yuen, A Ayres, SM Crowe, A Bartholomeusz, SA Locarnini, A Mijch, SR Lewin and J Sasadeusz

    Article first published online : 28 JAN 2009, DOI: 10.1111/j.1468-1293.2008.00675.x

  10. Tenofovir: Quo Vadis Anno 2012 (Where Is It Going in the Year 2012)?

    Medicinal Research Reviews

    Volume 32, Issue 4, July 2012, Pages: 765–785, Erik De Clercq

    Article first published online : 11 MAY 2012, DOI: 10.1002/med.21267

  11. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals

    Intervention Review

    The Cochrane Library

    Charles I Okwundu, Olalekan A Uthman and Christy AN Okoromah

    Published Online : 11 JUL 2012, DOI: 10.1002/14651858.CD007189.pub3

  12. You have full text access to this OnlineOpen article
    Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy

    HIV Medicine

    Volume 7, Issue 2, March 2006, Pages: 105–111, A Winston, J Amin, PWG Mallon, D Marriott, A Carr, DA Cooper and S Emery

    Article first published online : 18 JAN 2006, DOI: 10.1111/j.1468-1293.2006.00349.x

  13. Fibre analysis and fibre digestibility in pet foods – a comparison of total dietary fibre, neutral and acid detergent fibre and crude fibre

    Journal of Animal Physiology and Animal Nutrition

    Volume 96, Issue 5, October 2012, Pages: 895–906, L. D. de-Oliveira, F. S. Takakura, E. Kienzle, M. A. Brunetto, E. Teshima, G. T. Pereira, R. S. Vasconcellos and A. C. Carciofi

    Article first published online : 3 AUG 2011, DOI: 10.1111/j.1439-0396.2011.01203.x

  14. You have full text access to this OnlineOpen article
    Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues

    Hepatology

    Volume 51, Issue 1, January 2010, Pages: 73–80, Florian van Bömmel, Robert A. de Man, Heiner Wedemeyer, Katja Deterding, Jörg Petersen, Peter Buggisch, Andreas Erhardt, Dietrich Hüppe, Kerstin Stein, Jörg Trojan, Christoph Sarrazin, Wulf O. Böcher, Ulrich Spengler, Hermann E. Wasmuth, Jurrien G.P. Reinders, Bernd Möller, Peter Rhode, Heinz-Hubert Feucht, Bertram Wiedenmann and Thomas Berg

    Article first published online : 25 AUG 2009, DOI: 10.1002/hep.23246

  15. You have full text access to this OnlineOpen article
    Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy

    HIV Medicine

    Volume 7, Issue 7, October 2006, Pages: 451–456, K Buchacz, JT Brooks, T Tong, AC Moorman, RK Baker, SD Holmberg and A Greenberg, the HIV Outpatient Study (HOPS) Investigators

    Article first published online : 22 AUG 2006, DOI: 10.1111/j.1468-1293.2006.00407.x

  16. Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV–HIV-coinfected patients

    Journal of Viral Hepatitis

    Volume 19, Issue 11, November 2012, Pages: 801–810, L. Kosi, T. Reiberger, B. A. Payer, K. Grabmeier-Pfistershammer, R. Strassl, A. Rieger and M. Peck-Radosavljevic

    Article first published online : 15 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01601.x

  17. Coexistence and divergence of tropical dry forests and savannas in southern Mexico

    Journal of Biogeography

    Volume 33, Issue 3, March 2006, Pages: 438–447, Eduardo A. Pérez-García and Jorge A. Meave

    Article first published online : 3 FEB 2006, DOI: 10.1111/j.1365-2699.2005.01459.x

  18. You have full text access to this OnlineOpen article
    Tenofovir-associated renal and bone toxicity

    HIV Medicine

    Volume 10, Issue 8, September 2009, Pages: 482–487, CLN Woodward, AM Hall, IG Williams, S Madge, A Copas, D Nair, SG Edwards, MA Johnson and JO Connolly

    Article first published online : 6 MAY 2009, DOI: 10.1111/j.1468-1293.2009.00716.x

  19. Tenofovir: what have over 1 million years of patient experience taught us?

    International Journal of Clinical Practice

    Volume 62, Issue 8, August 2008, Pages: 1285–1293, A. Pozniak

    Article first published online : 10 JUL 2008, DOI: 10.1111/j.1742-1241.2008.01817.x